Table 1. Potential causes and consequences of proposed BBB dysfunction in AD.
BBB dysfunction | Upstream causes | Downstream consequences | ||
---|---|---|---|---|
Disruption | Aβ oligomers, truncated tau, inflammation, oxidative stress, diabetes, ApoE4 allele, TBI, vascular disease | Leakage of serum components into CNS, neurotoxicity, inflammatory activation | ||
Altered transport | Of Aβ | ↓LRP-1 | Aβ oligomers, inflammation, oxidative stress, diabetes | Aβ accumulation in the CNS |
↓Pgp | Aβ oligomers, inflammation, TBI | Aβ accumulation in the CNS, altered xenobiotic transport | ||
↑RAGE | Aβ oligomers, diabetes, inflammation, oxidative stress | Aβ accumulation in the CNS, vascular inflammation | ||
Of glucose | ↓GLUT-1 | Aβ oligomers, ApoE4 allele | Energy deprivation, neuronal dysfunction | |
Altered secretions | Of thrombin | Oxidative stress, ischemia | Neurotoxicity, BBB disruption | |
Of VEGF | Oxidative stress, ischemia | Neurotoxicity, BBB disruption, angiogenesis |
Aβ, amyloid-β; AD, Alzheimer's disease; ApoE, Apolipoprotein E; BBB, blood–brain barrier; CNS, central nervous system; LRP-1, lipoprotein receptor-related protein-1; Pgp, P-glycoprotein; RAGE, receptor for advanced glycation endproducts; TBI, traumatic brain injury; VEGF, vascular endothelial growth factor.